Cardiotonic steroids on the road to anti-cancer therapy
T Mijatovic, E Van Quaquebeke, B Delest… - … et Biophysica Acta (BBA …, 2007 - Elsevier
The sodium pump, Na+/K+-ATPase, could be an important target for the development of anti-
cancer drugs as it serves as a versatile signal transducer, it is a key player in cell adhesion …
cancer drugs as it serves as a versatile signal transducer, it is a key player in cell adhesion …
Национальные рекомендации ВНОК и ОССН по диагностике и лечению ХСН (третий пересмотр)(утверждены конференцией ОССН 15 декабря 2009 года)
ВЮ Мареев, ФТ Агеев, ГП Арутюнов… - Журнал сердечная …, 2010 - elibrary.ru
Введение В короткой преамбуле хочется предпослать этому доку менту несколько
определяющих позиций: Принятие в 2003 и 2006 годах съездами ВНок Нацио 1 …
определяющих позиций: Принятие в 2003 и 2006 годах съездами ВНок Нацио 1 …
Treatment targets for right ventricular dysfunction in pulmonary arterial hypertension
Right ventricle (RV) dysfunction is the strongest predictor of mortality in pulmonary arterial
hypertension (PAH), but, at present, there are no therapies directly targeting the failing RV …
hypertension (PAH), but, at present, there are no therapies directly targeting the failing RV …
[HTML][HTML] Discovery and characterization of a prevalent human gut bacterial enzyme sufficient for the inactivation of a family of plant toxins
Although the human gut microbiome plays a prominent role in xenobiotic transformation,
most of the genes and enzymes responsible for this metabolism are unknown. Recently, we …
most of the genes and enzymes responsible for this metabolism are unknown. Recently, we …
Contemporary use of digoxin in the management of cardiovascular disorders
M Gheorghiade, DJ Van Veldhuisen, WS Colucci - Circulation, 2006 - Am Heart Assoc
Digitalis is the oldest compound in cardiovascular medicine that continues to be used in
contemporary clinical practice. 1 Evidence supporting the beneficial effects of digoxin on …
contemporary clinical practice. 1 Evidence supporting the beneficial effects of digoxin on …
CRISPR/Cas12a-powered competitive immunosorbent assay for small molecules
F Zhu, Q Zhao - Analytical Chemistry, 2023 - ACS Publications
CRISPR/Cas systems are powerful tools for sensitive nucleic acid molecular diagnosis due
to their specific nucleic acid recognition and high trans-cleavage activity and have also …
to their specific nucleic acid recognition and high trans-cleavage activity and have also …
Trial watch: cardiac glycosides and cancer therapy
L Menger, E Vacchelli, O Kepp, A Eggermont… - …, 2013 - Taylor & Francis
Cardiac glycosides (CGs) are natural compounds sharing the ability to operate as potent
inhibitors of the plasma membrane Na+/K+-ATPase, hence promoting—via an indirect …
inhibitors of the plasma membrane Na+/K+-ATPase, hence promoting—via an indirect …
Targeting the α 1 subunit of the sodium pump to combat glioblastoma cells
F Lefranc, T Mijatovic, Y Kondo, S Sauvage… - …, 2008 - journals.lww.com
OBJECTIVE: Ion transporters play pivotal roles in cancer cell migration in general and in
glioblastomas (GBMs) in particular. However, the specific role of Na+/K+-ATPase (the …
glioblastomas (GBMs) in particular. However, the specific role of Na+/K+-ATPase (the …
Marinobufagenin stimulates fibroblast collagen production and causes fibrosis in experimental uremic cardiomyopathy
J Elkareh, DJ Kennedy, B Yashaswi, S Vetteth… - …, 2007 - Am Heart Assoc
We have observed recently that experimental renal failure in the rat is accompanied by
increases in circulating concentrations of the cardiotonic steroid, marinobufagenin (MBG) …
increases in circulating concentrations of the cardiotonic steroid, marinobufagenin (MBG) …
Digoxin: clinical highlights: a review of digoxin and its use in contemporary medicine
M Ehle, C Patel, RP Giugliano - Critical pathways in cardiology, 2011 - journals.lww.com
Digoxin is the oldest cardiac medication used in contemporary medicine. With a complex
pharmacokinetic profile and narrow therapeutic index, its use in managing patients with …
pharmacokinetic profile and narrow therapeutic index, its use in managing patients with …